Endogenous DNA Damage as a Source of Genomic Instability in Cancer

Cell

Volumn 168, Issue 4, 2017, Pages 644-656

  Tubbs, Anthony ^a   Nussenzweig, André ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cancer; DNA damage; DNA repair; DNA replication; Genome instability; mutagenesis; transcription

Indexed keywords

CYTOSINE DEAMINASE; DNA; DNA TOPOISOMERASE; SINGLE STRANDED DNA; CHROMATIN;

CHROMATIN; CHROMOSOME REARRANGEMENT; DEAMINATION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; GENE ACTIVATION; GENE DELETION; GENE EDITING; GENE INSERTION; GENE MUTATION; GENE REARRANGEMENT; GENOME; GENOMIC INSTABILITY; HUMAN; INDEL MUTATION; MALIGNANT NEOPLASM; MOLECULAR EVOLUTION; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE; PRIORITY JOURNAL; REVIEW; STOCHASTIC MODEL; CHEMISTRY; GENETICS; MUTATION; NEOPLASM; TRANSCRIPTION INITIATION;

CHROMATIN; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; GENOMIC INSTABILITY; HUMANS; MUTATION; NEOPLASMS; TRANSCRIPTIONAL ACTIVATION;

EID: 85011950306     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.01.002     Document Type: Review

References (94)

1. Aguilera, A., The connection between transcription and genomic instability. EMBO J. 21 (2002), 195–201.
2. Alexandrov, L.B., Stratton, M.R., Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr. Opin. Genet. Dev. 24 (2014), 52–60.
3. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Børresen-Dale, A.L., et al. Australian Pancreatic Cancer Genome Initiative ICGC Breast Cancer Consortium ICGC MMML-Seq Consortium, ICGC PedBrain. Signatures of mutational processes in human cancer. Nature 500 (2013), 415–421.
4. Baca, S.C., Prandi, D., Lawrence, M.S., Mosquera, J.M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T.Y., Ghandi, M., et al. Punctuated evolution of prostate cancer genomes. Cell 153 (2013), 666–677.
5. Banerjee, A., Santos, W.L., Verdine, G.L., Structure of a DNA glycosylase searching for lesions. Science 311 (2006), 1153–1157.
6. Barlow, J.H., Faryabi, R.B., Callén, E., Wong, N., Malhowski, A., Chen, H.T., Gutierrez-Cruz, G., Sun, H.W., McKinnon, P., Wright, G., et al. Identification of early replicating fragile sites that contribute to genome instability. Cell 152 (2013), 620–632.
7. Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., Huch, M., Boymans, S., Kuijk, E., Prins, P., et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538 (2016), 260–264.
8. Bunch, H., Lawney, B.P., Lin, Y.F., Asaithamby, A., Murshid, A., Wang, Y.E., Chen, B.P., Calderwood, S.K., Transcriptional elongation requires DNA break-induced signalling. Nat. Commun., 6, 2015, 10191.
9. Burns, M.B., Lackey, L., Carpenter, M.A., Rathore, A., Land, A.M., Leonard, B., Refsland, E.W., Kotandeniya, D., Tretyakova, N., Nikas, J.B., et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494 (2013), 366–370.
10. Calderwood, S.K., A critical role for topoisomerase IIb and DNA double strand breaks in transcription. Transcription 7 (2016), 75–83.
11. Canela, A., Sridharan, S., Sciascia, N., Tubbs, A., Meltzer, P., Sleckman, B.P., Nussenzweig, A., DNA Breaks and End Resection Measured Genome-wide by End Sequencing. Mol. Cell 63 (2016), 898–911.
12. Chiarle, R., Zhang, Y., Frock, R.L., Lewis, S.M., Molinie, B., Ho, Y.J., Myers, D.R., Choi, V.W., Compagno, M., Malkin, D.J., et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 147 (2011), 107–119.
13. Chiolo, I., Minoda, A., Colmenares, S.U., Polyzos, A., Costes, S.V., Karpen, G.H., Double-strand breaks in heterochromatin move outside of a dynamic HP1a domain to complete recombinational repair. Cell 144 (2011), 732–744.
14. Cortez, D., Preventing replication fork collapse to maintain genome integrity. DNA Repair (Amst.) 32 (2015), 149–157.
15. Crick, F., The double helix: a personal view. Nature 248 (1974), 766–769.
16. Datta, A., Jinks-Robertson, S., Association of increased spontaneous mutation rates with high levels of transcription in yeast. Science 268 (1995), 1616–1619.
17. De Marzo, A.M., Platz, E.A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C.G., Nakai, Y., Isaacs, W.B., Nelson, W.G., Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7 (2007), 256–269.
18. Di Noia, J.M., Neuberger, M.S., Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76 (2007), 1–22.
19. Friedberg, E.C., A brief history of the DNA repair field. Cell Res. 18 (2008), 3–7.
20. Frock, R.L., Hu, J., Meyers, R.M., Ho, Y.J., Kii, E., Alt, F.W., Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 33 (2015), 179–186.
21. Gao, R., Davis, A., McDonald, T.O., Sei, E., Shi, X., Wang, Y., Tsai, P.C., Casasent, A., Waters, J., Zhang, H., et al. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat. Genet. 48 (2016), 1119–1130.
22. Goodarzi, A.A., Noon, A.T., Deckbar, D., Ziv, Y., Shiloh, Y., Löbrich, M., Jeggo, P.A., ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 31 (2008), 167–177.
23. Goodman, M.F., Woodgate, R., Translesion DNA polymerases. Cold Spring Harb. Perspect. Biol., 5, 2013, a010363.
24. Haber, J.E., Deciphering the DNA Damage Response. Cell 162 (2015), 1183–1185.
25. Haffner, M.C., Aryee, M.J., Toubaji, A., Esopi, D.M., Albadine, R., Gurel, B., Isaacs, W.B., Bova, G.S., Liu, W., Xu, J., et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat. Genet. 42 (2010), 668–675.
26. Halazonetis, T.D., Gorgoulis, V.G., Bartek, J., An oncogene-induced DNA damage model for cancer development. Science 319 (2008), 1352–1355.
27. Haradhvala, N.J., Polak, P., Stojanov, P., Covington, K.R., Shinbrot, E., Hess, J.M., Rheinbay, E., Kim, J., Maruvka, Y.E., Braunstein, L.Z., et al. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair. Cell 164 (2016), 538–549.
28. Harman, D., Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956), 298–300.
29. Helleday, T., Eshtad, S., Nik-Zainal, S., Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15 (2014), 585–598.
30. Ju, B.G., Lunyak, V.V., Perissi, V., Garcia-Bassets, I., Rose, D.W., Glass, C.K., Rosenfeld, M.G., A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312 (2006), 1798–1802.
31. Kantidakis, T., Saponaro, M., Mitter, R., Horswell, S., Kranz, A., Boeing, S., Aygün, O., Kelly, G.P., Matthews, N., Stewart, A., et al. Mutation of cancer driver MLL2 results in transcription stress and genome instability. Genes Dev. 30 (2016), 408–420.
32. Kanu, N., Cerone, M.A., Goh, G., Zalmas, L.P., Bartkova, J., Dietzen, M., McGranahan, N., Rogers, R., Law, E.K., Gromova, I., et al. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer. Genome Biol., 17, 2016, 185.
33. Kennedy, S.R., Salk, J.J., Schmitt, M.W., Loeb, L.A., Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage. PLoS Genet., 9, 2013, e1003794.
34. Klein, I.A., Resch, W., Jankovic, M., Oliveira, T., Yamane, A., Nakahashi, H., Di Virgilio, M., Bothmer, A., Nussenzweig, A., Robbiani, D.F., et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147 (2011), 95–106.
35. Komor, A.C., Kim, Y.B., Packer, M.S., Zuris, J.A., Liu, D.R., Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533 (2016), 420–424.
36. Kunkel, T.A., Celebrating DNA's Repair Crew. Cell 163 (2015), 1301–1303.
37. Law, E.K., Sieuwerts, A.M., LaPara, K., Leonard, B., Starrett, G.J., Molan, A.M., Temiz, N.A., Vogel, R.I., Meijer-van Gelder, M.E., Sweep, F.C., et al. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Sci. Adv., 2, 2016, e1601737.
38. Lawrence, M.S., Stojanov, P., Mermel, C.H., Robinson, J.T., Garraway, L.A., Golub, T.R., Meyerson, M., Gabriel, S.B., Lander, E.S., Getz, G., Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505 (2014), 495–501.
39. Lee, J.E., Wang, C., Xu, S., Cho, Y.W., Wang, L., Feng, X., Baldridge, A., Sartorelli, V., Zhuang, L., Peng, W., Ge, K., H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. eLife, 2, 2013, e01503.
40. Lensing, S.V., Marsico, G., Hänsel-Hertsch, R., Lam, E.Y., Tannahill, D., Balasubramanian, S., DSBCapture: in situ capture and sequencing of DNA breaks. Nat. Methods 13 (2016), 855–857.
41. Lin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.G., Ohgi, K., Zhang, J., Rose, D.W., Fu, X.D., Glass, C.K., Rosenfeld, M.G., Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139 (2009), 1069–1083.
42. Lindahl, T., Instability and decay of the primary structure of DNA. Nature 362 (1993), 709–715.
43. Lindahl, T., Barnes, D.E., Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 65 (2000), 127–133.
44. Lindahl, T., Nyberg, B., Rate of depurination of native deoxyribonucleic acid. Biochemistry 11 (1972), 3610–3618.
45. Lippert, M.J., Kim, N., Cho, J.E., Larson, R.P., Schoenly, N.E., O'Shea, S.H., Jinks-Robertson, S., Role for topoisomerase 1 in transcription-associated mutagenesis in yeast. Proc. Natl. Acad. Sci. USA 108 (2011), 698–703.
46. Liu, M., Schatz, D.G., Balancing AID and DNA repair during somatic hypermutation. Trends Immunol. 30 (2009), 173–181.
47. Liu, M., Duke, J.L., Richter, D.J., Vinuesa, C.G., Goodnow, C.C., Kleinstein, S.H., Schatz, D.G., Two levels of protection for the B cell genome during somatic hypermutation. Nature 451 (2008), 841–845.
48. Lodato, M.A., Woodworth, M.B., Lee, S., Evrony, G.D., Mehta, B.K., Karger, A., Lee, S., Chittenden, T.W., D'Gama, A.M., Cai, X., et al. Somatic mutation in single human neurons tracks developmental and transcriptional history. Science 350 (2015), 94–98.
49. Loeb, L.A., Springgate, C.F., Battula, N., Errors in DNA replication as a basis of malignant changes. Cancer Res. 34 (1974), 2311–2321.
50. Lord, C.J., Tutt, A.N., Ashworth, A., Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors. Annu. Rev. Med. 66 (2015), 455–470.
51. Madabhushi, R., Gao, F., Pfenning, A.R., Pan, L., Yamakawa, S., Seo, J., Rueda, R., Phan, T.X., Yamakawa, H., Pao, P.C., et al. Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes. Cell 161 (2015), 1592–1605.
52. McKinnon, P.J., Maintaining genome stability in the nervous system. Nat. Neurosci. 16 (2013), 1523–1529.
53. Meng, F.L., Du, Z., Federation, A., Hu, J., Wang, Q., Kieffer-Kwon, K.R., Meyers, R.M., Amor, C., Wasserman, C.R., Neuberg, D., et al. Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability. Cell 159 (2014), 1538–1548.
54. Morganella, S., Alexandrov, L.B., Glodzik, D., Zou, X., Davies, H., Staaf, J., Sieuwerts, A.M., Brinkman, A.B., Martin, S., Ramakrishna, M., et al. The topography of mutational processes in breast cancer genomes. Nat. Commun., 7, 2016, 11383.
55. Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D.R., Tessarollo, L., Casellas, R., et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151 (2012), 68–79.
56. Nik-Zainal, S., Alexandrov, L.B., Wedge, D.C., Van Loo, P., Greenman, C.D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L.A., et al., Breast Cancer Working Group of the International Cancer Genome Consortium. Mutational processes molding the genomes of 21 breast cancers. Cell 149 (2012), 979–993.
57. Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L.B., Martin, S., Wedge, D.C., et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534 (2016), 47–54.
58. Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K.Y., et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science, 353, 2016.
59. Notta, F., Chan-Seng-Yue, M., Lemire, M., Li, Y., Wilson, G.W., Connor, A.A., Denroche, R.E., Liang, S.B., Brown, A.M., Kim, J.C., et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538 (2016), 378–382.
60. Nowell, P.C., The clonal evolution of tumor cell populations. Science 194 (1976), 23–28.
61. Olivier, M., Hollstein, M., Hainaut, P., TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol., 2, 2010, a001008.
62. Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K.M., Gregg, A., Noggle, S., Tessier-Lavigne, M., Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533 (2016), 125–129.
63. Perera, D., Poulos, R.C., Shah, A., Beck, D., Pimanda, J.E., Wong, J.W., Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes. Nature 532 (2016), 259–263.
64. Perillo, B., Ombra, M.N., Bertoni, A., Cuozzo, C., Sacchetti, S., Sasso, A., Chiariotti, L., Malorni, A., Abbondanza, C., Avvedimento, E.V., DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319 (2008), 202–206.
65. Periyasamy, M., Patel, H., Lai, C.F., Nguyen, V.T., Nevedomskaya, E., Harrod, A., Russell, R., Remenyi, J., Ochocka, A.M., Thomas, R.S., et al. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer. Cell Rep. 13 (2015), 108–121.
66. Pommier, Y., Sun, Y., Huang, S.N., Nitiss, J.L., Roles of eukaryotic topoisomerases in transcription, replication and genomic stability. Nat. Rev. Mol. Cell Biol. 17 (2016), 703–721.
67. Pritchard, C.C., Mateo, J., Walsh, M.F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. N. Engl. J. Med. 375 (2016), 443–453.
68. Qian, J., Wang, Q., Dose, M., Pruett, N., Kieffer-Kwon, K.R., Resch, W., Liang, G., Tang, Z., Mathé, E., Benner, C., et al. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell 159 (2014), 1524–1537.
69. Ray Chaudhuri, A., Callen, E., Ding, X., Gogola, E., Duarte, A.A., Lee, J.E., Wong, N., Lafarga, V., Calvo, J.A., Panzarino, N.J., et al. Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature 535 (2016), 382–387.
70. Rialdi, A., Campisi, L., Zhao, N., Lagda, A.C., Pietzsch, C., Ho, J.S., Martinez-Gil, L., Fenouil, R., Chen, X., Edwards, M., et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science, 352, 2016, aad7993.
71. Sabarinathan, R., Mularoni, L., Deu-Pons, J., Gonzalez-Perez, A., López-Bigas, N., Nucleotide excision repair is impaired by binding of transcription factors to DNA. Nature 532 (2016), 264–267.
72. Sankar, T.S., Wastuwidyaningtyas, B.D., Dong, Y., Lewis, S.A., Wang, J.D., The nature of mutations induced by replication–transcription collisions. Nature 535 (2016), 178–181.
73. Saponaro, M., Kantidakis, T., Mitter, R., Kelly, G.P., Heron, M., Williams, H., Söding, J., Stewart, A., Svejstrup, J.Q., RECQL5 controls transcript elongation and suppresses genome instability associated with transcription stress. Cell 157 (2014), 1037–1049.
74. Sarni, D., Kerem, B., The complex nature of fragile site plasticity and its importance in cancer. Curr. Opin. Cell Biol. 40 (2016), 131–136.
75. Scarano, E., Iaccarino, M., Grippo, P., Parisi, E., The heterogeneity of thymine methyl group origin in DNA pyrimidine isostichs of developing sea urchin embryos. Proc. Natl. Acad. Sci. USA 57 (1967), 1394–1400.
76. Schumacher, T.N., Schreiber, R.D., Neoantigens in cancer immunotherapy. Science 348 (2015), 69–74.
77. Schuster-Böckler, B., Lehner, B., Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488 (2012), 504–507.
78. Shlien, A., Campbell, B.B., de Borja, R., Alexandrov, L.B., Merico, D., Wedge, D., Van Loo, P., Tarpey, P.S., Coupland, P., Behjati, S., et al., Biallelic Mismatch Repair Deficiency Consortium. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat. Genet. 47 (2015), 257–262.
79. Sima, J., Gilbert, D.M., Complex correlations: replication timing and mutational landscapes during cancer and genome evolution. Curr. Opin. Genet. Dev. 25 (2014), 93–100.
80. Stork, C.T., Bocek, M., Crossley, M.P., Sollier, J., Sanz, L.A., Chédin, F., Swigut, T., Cimprich, K.A., Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage. eLife, 5, 2016.
81. Supek, F., Lehner, B., Differential DNA mismatch repair underlies mutation rate variation across the human genome. Nature 521 (2015), 81–84.
82. Supek, F., Lehner, B., Hajkova, P., Warnecke, T., Hydroxymethylated cytosines are associated with elevated C to G transversion rates. PLoS Genet., 10, 2014, e1004585.
83. Swanton, C., McGranahan, N., Starrett, G.J., Harris, R.S., APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity. Cancer Discov. 5 (2015), 704–712.
84. Takahashi, T., Burguiere-Slezak, G., Van der Kemp, P.A., Boiteux, S., Topoisomerase 1 provokes the formation of short deletions in repeated sequences upon high transcription in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 108 (2011), 692–697.
85. Tomasetti, C., Vogelstein, B., Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347 (2015), 78–81.
86. Tsouroula, K., Furst, A., Rogier, M., Heyer, V., Maglott-Roth, A., Ferrand, A., Reina-San-Martin, B., Soutoglou, E., Temporal and Spatial Uncoupling of DNA Double Strand Break Repair Pathways within Mammalian Heterochromatin. Mol. Cell 63 (2016), 293–305.
87. Waters, L.S., Walker, G.C., The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase. Proc. Natl. Acad. Sci. USA 103 (2006), 8971–8976.
88. Wei, P.C., Chang, A.N., Kao, J., Du, Z., Meyers, R.M., Alt, F.W., Schwer, B., Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells. Cell 164 (2016), 644–655.
89. Williamson, L.M., Lees-Miller, S.P., Estrogen receptor α-mediated transcription induces cell cycle-dependent DNA double-strand breaks. Carcinogenesis 32 (2011), 279–285.
90. Wong, R.H., Chang, I., Hudak, C.S., Hyun, S., Kwan, H.Y., Sul, H.S., A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell 136 (2009), 1056–1072.
91. Wu, S., Powers, S., Zhu, W., Hannun, Y.A., Substantial contribution of extrinsic risk factors to cancer development. Nature 529 (2016), 43–47.
92. Zhang, C.Z., Leibowitz, M.L., Pellman, D., Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev. 27 (2013), 2513–2530.
93. Zhang, C.Z., Spektor, A., Cornils, H., Francis, J.M., Jackson, E.K., Liu, S., Meyerson, M., Pellman, D., Chromothripsis from DNA damage in micronuclei. Nature 522 (2015), 179–184.
94. Zheng, C.L., Wang, N.J., Chung, J., Moslehi, H., Sanborn, J.Z., Hur, J.S., Collisson, E.A., Vemula, S.S., Naujokas, A., Chiotti, K.E., et al. Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes. Cell Rep. 9 (2014), 1228–1234.